BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30207575)

  • 1. Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis.
    Kim SK; Choe JY
    Arch Rheumatol; 2018 Jun; 33(2):143-149. PubMed ID: 30207575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
    Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis.
    Nielung L; Christensen R; Danneskiold-Samsøe B; Bliddal H; Holm CC; Ellegaard K; Slott Jensen H; Bartels EM
    Arthritis; 2015; 2015():401690. PubMed ID: 25632353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA.
    Söderlin MK; Petersson IF; Bergman S; Svensson B;
    Scand J Rheumatol; 2011; 40(4):249-55. PubMed ID: 21338325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database.
    Naranjo A; Toloza S; Guimaraes da Silveira I; Lazovskis J; Hetland ML; Hamoud H; Peets T; Mäkinen H; Gossec L; Herborn G; Skopouli FN; Rojkovich B; Aggarwal A; Minnock P; Cazzato M; Yamanaka H; Oyoo O; Rexhepi S; Andersone D; Baranauskaite A; Hajjaj-Hassouni N; Jacobs JW; Haugeberg G; Sierakowski S; Ionescu R; Karateew D; Dimic A; Henrohn D; Gogus F; Badsha H; Choy E; Bergman M; Sokka T
    Clin Exp Rheumatol; 2010; 28(6):820-7. PubMed ID: 21205460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?
    Torrente-Segarra V; Bergstra SA; Solomon-Escoto K; Da Silva J; Veale DJ; Al-Emadi S; Huizinga T
    Scand J Rheumatol; 2018 Sep; 47(5):360-363. PubMed ID: 29683356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration.
    Chatzidionysiou K; Lukina G; Gabay C; Hetland ML; Hauge EM; Pavelka K; Nordström D; Canhão H; Tomsic M; Rotar Z; Lie E; Kvien TK; van Vollenhoven RF; Saevarsdottir S
    Scand J Rheumatol; 2019 Jan; 48(1):17-23. PubMed ID: 30260261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAS28-CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28-ESR in Rheumatoid Arthritis.
    Greenmyer JR; Stacy JM; Sahmoun AE; Beal JR; Diri E
    ACR Open Rheumatol; 2020 Sep; 2(9):507-511. PubMed ID: 32862564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAS28-ESR and DAS28-CRP - are they Interchangeable in Measuring the Activity of Rheumatoid Arthritis in Response to Treatment with Biological Agents?
    Shivacheva TK
    Folia Med (Plovdiv); 2020 Mar; 62(1):46-51. PubMed ID: 32337896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
    Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
    Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life.
    Sunar İ; Ataman Ş
    Arch Rheumatol; 2020 Jun; 35(2):247-253. PubMed ID: 32851374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis.
    Huang H; Cen H; Zhou L; Wang TH; Qin W; Xie BH; Xiao DM; Wu XD; Wu HX
    Arch Rheumatol; 2019 Dec; 34(4):406-413. PubMed ID: 32010889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP.
    Romanowska-Próchnicka K; Olesińska M; Paradowska-Gorycka A; Mańczak M; Felis-Giemza A; Wojdasiewicz P; Szukiewicz D
    Cent Eur J Immunol; 2016; 41(2):188-94. PubMed ID: 27536205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 19. DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable.
    Fleischmann RM; van der Heijde D; Gardiner PV; Szumski A; Marshall L; Bananis E
    RMD Open; 2017; 3(1):e000382. PubMed ID: 28255449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.